{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:15:05Z","timestamp":1774790105285,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T00:00:00Z","timestamp":1154995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T00:00:00Z","timestamp":1154995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1111\/j.1365-2133.2006.07451.x","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T19:41:56Z","timestamp":1155066116000},"page":"1053-1056","source":"Crossref","is-referenced-by-count":74,"title":["Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma"],"prefix":"10.1093","volume":"155","author":[{"given":"G.","family":"Perceau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Diris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Estines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Derancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,8,8]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1200\/JCO.2004.04.020","article-title":"Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9\u2003year follow-up","volume":"22","author":"Csuzman","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.55.091902.104249","article-title":"Rituximab: expanding role in therapy for lymphomas and autoimmune diseases","volume":"55","author":"Rastetter","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB3|cit3","first-page":"1152","article-title":"Cutaneous B-cell lymphoma treatment with rituximab: two cases","volume":"129","author":"Viguier","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1365-2133.2001.04241.x","article-title":"Intralesional rituximab for cutaneous B-cell lymphoma","volume":"144","author":"Paul","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00432-001-0313-2","article-title":"Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab","volume":"128","author":"Bonnekoh","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","article-title":"Rituximab treatment results in impaired secondary humoral immune responsiveness","volume":"100","author":"Van Der Kolk","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s002770100346","article-title":"Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report","volume":"80","author":"Ng","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/sj.leu.2402567","article-title":"Treatment of HBV-carrying lymphoma patients with rituximab and CHOP: a diagnostic and therapeutic challenge","volume":"16","author":"Skrabs","year":"2002","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB11|cit11","first-page":"ECR22","article-title":"Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab","volume":"88","author":"Hernandez","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00277-004-0899-y","article-title":"Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP","volume":"83","author":"Dai","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/1042819031000151923","article-title":"Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy","volume":"45","author":"Tsutsumi","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/MO:21:1:67","article-title":"Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma","volume":"21","author":"Ozguroglu","year":"2004","journal-title":"Med Oncol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.thj.6200396","article-title":"Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies","volume":"5","author":"Pelizzari","year":"2004","journal-title":"Hematol J"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0609.2004.00376.x","article-title":"Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy","volume":"74","author":"Takai","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.2004.00375.x","article-title":"Hepatitis B virus reactivation and alemtuzumab therapy","volume":"74","author":"Iannitto","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00277-003-0748-4","article-title":"Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma","volume":"83","author":"Tsutsumi","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.thj.6200243","article-title":"Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection","volume":"4","author":"Kami","year":"2003","journal-title":"Hematol J"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon \u03b1 with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.10043","article-title":"Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab","volume":"68","author":"Hamaki","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2893.2003.00479.x","article-title":"Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies","volume":"11","author":"Idilman","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2133.2006.07451.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07451.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07451.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07451.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:18:27Z","timestamp":1676384307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/155\/5\/1053\/6637308"}},"subtitle":["Fatal rituximab reactivation of HBV"],"short-title":[],"issued":{"date-parts":[[2006,8,8]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07451.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8,8]]}}}